Skip to main content
Eduardo Sotomayor, MD, Oncology, Tampa, FL, Tampa General Hospital

EduardoMSotomayorMD

Oncology • Tampa, FL

Associate Professor of Medicine, University S Fla College of Medicine

Join to view full profile

Dr. Sotomayor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sotomayor's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1992 - 1995
  • National University of Federico Villarreal Faculty of Medicine
    National University of Federico Villarreal Faculty of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2000 - 2026
  • DC State Medical License
    DC State Medical License 2015 - 2022
  • MD State Medical License
    MD State Medical License 1995 - 2021

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2007-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Stu...
    Eduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Gro...
    Eduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study ...
    Eduardo Sotomayor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Loss of HDAC11 Promotes Myeloid-Derived Suppressor Cells Inhibition of T Cell Function in a Murine Lymphoma Microenvironment 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s Life
    Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s LifeApril 1st, 2023
  • Tampa General Hospital Cancer Institute Expands Its Radiation Oncology Program with World-Renowned Physicians and a State-of-the-Art Proton Therapy Center, Bringing Greater Access to Best-in-Class Cancer Treatment to Patients
    Tampa General Hospital Cancer Institute Expands Its Radiation Oncology Program with World-Renowned Physicians and a State-of-the-Art Proton Therapy Center, Bringing Greater Access to Best-in-Class Cancer Treatment to PatientsJanuary 13th, 2023
  • Tampa General Hospital Cancer Institute Is Expanding and Now Providing Comprehensive Cancer Treatment Services to the Brandon Area and Surrounding Communities
    Tampa General Hospital Cancer Institute Is Expanding and Now Providing Comprehensive Cancer Treatment Services to the Brandon Area and Surrounding CommunitiesNovember 9th, 2022
  • Join now to see all

Grant Support

  • Targeting Negative Regulatory Pathways For Immunotherapy Of B-Cell LymphomasNational Cancer Institute2010–2012
  • Regulation Of Cross-Tolerance To Tumor AntigensNational Cancer Institute2003–2012
  • Solid Tumors Induced T-Cell ToleranceNational Cancer Institute2005–2009
  • Solid Tumors Induced T Cell ToleranceNational Cancer Institute2001–2004
  • Mechanism(S) Involved In Tumor Induced ToleranceNational Cancer Institute1999–2001
  • Mechanism(S) Involved In Tumor Induced ToleranceNational Cancer Institute1998

Hospital Affiliations

Dr. Eduardo Sotomayor, Dr. Eduardo Sotomayor, MD, Dr. E Sotomayor, Dr. Eduardo M Sotomayor